Myopia Management with Misight

BRACES FOR THE EYE

Nearsightedness, or myopia, is the most common refractive error of the eye. Though the exact cause for this increase in nearsightedness among Americans is unknown, many eye doctors feel it has something to do with eye fatigue from computer use and other extended near vision tasks, coupled with a genetic predisposition for myopia.

If you are nearsighted, you typically will have difficulty reading road signs and seeing distant objects clearly, but will be able to see well for close-up tasks such as reading and computer use. Other signs and symptoms of myopia include squinting, eye strain and headaches. Feeling fatigued when driving or playing sports also can be a symptom of uncorrected nearsightedness.

Nearsightedness can be corrected with glasses, contact lenses or refractive surgery. Depending on the degree of your myopia, you may need to wear your glasses or contact lenses all the time or only when you need very clear distance vision, like when driving, seeing a chalkboard or watching a movie.

You have an option for soft contact to wear in the daytime or hard contact at night and no contact in daytime. This is for myopia management. Abiliti™ Overnight lenses are orthokeratology contact lenses that help manage myopia. There is also an option for atropine eye drops in daytime.

WE ARE A BRILLIANT FUTURES™ WITH MISIGHT® CERTIFIED EYE CARE PROFESSIONAL

Kids lead active, jam-packed lives. But whether they’re playing pretend, riding bikes with their friends, or learning new things at school, myopia (nearsightedness) can make it harder for them to engage in the activities they love.

Your age-appropriate children may benefit from an innovative technology to help slow down the progression of their myopia1*: MiSight® 1 day contact lenses from CooperVision. MiSight 1 day contact lenses with ActivControl® Technology not only correct nearsightedness – they’re also the first soft contact lenses proven to slow the progression of myopia in children in children aged 8-12 at initiation of treatment.
​​​​​​​

Content Source: CooperVision